Clinical Trials
- Diabetes
Physiologic Markers of Cardiometabolic Risk in People With Type 1 Diabetes
- Diabetes
Type 2 Diabetes Ultrasound Study
- Ages21 years - 75 years
- GenderBoth
- Children's Health, Diabetes, Endocrine System
Pathway to Prevention
- Ages1 year - 45 years
- GenderBoth
- Diabetes, Blood Disorders, Liver, Immune System
Semaglutide Effects in Obese Youth With Prediabetes/New Onset Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease